(S)-1-(1-(2-Aminopyrimidin-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-yl)-3-methylpent-1-yn-3-ol

ID: ALA5283456

Chembl Id: CHEMBL5283456

Max Phase: Preclinical

Molecular Formula: C17H17N5O

Molecular Weight: 307.36

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@](C)(O)C#Cc1cc2c(ccn2-c2ccnc(N)n2)cn1

Standard InChI:  InChI=1S/C17H17N5O/c1-3-17(2,23)7-4-13-10-14-12(11-20-13)6-9-22(14)15-5-8-19-16(18)21-15/h5-6,8-11,23H,3H2,1-2H3,(H2,18,19,21)/t17-/m0/s1

Standard InChI Key:  ISYRCGISNANONJ-KRWDZBQOSA-N

Alternative Forms

  1. Parent:

    ALA5283456

    ---

Associated Targets(Human)

TTBK1 Tbio Tau-tubulin kinase 1 (179 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TTBK2 Tbio Tau-tubulin kinase 2 (107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP3K14 Tchem Mitogen-activated protein kinase kinase kinase 14 (1412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 307.36Molecular Weight (Monoisotopic): 307.1433AlogP: 1.91#Rotatable Bonds: 2
Polar Surface Area: 89.85Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.32CX Basic pKa: 6.39CX LogP: 2.57CX LogD: 2.54
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.71Np Likeness Score: -0.51

References

1. Halkina T, Henderson JL, Lin EY, Himmelbauer MK, Jones JH, Nevalainen M, Feng J, King K, Rooney M, Johnson JL, Marcotte DJ, Chodaparambil JV, Kumar PR, Patterson TA, Murugan P, Schuman E, Wong L, Hesson T, Lamore S, Bao C, Calhoun M, Certo H, Amaral B, Dillon GM, Gilfillan R, de Turiso FG..  (2021)  Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In Vivo.,  64  (9.0): [PMID:33944571] [10.1021/acs.jmedchem.1c00382]

Source